176 related articles for article (PubMed ID: 23429603)
1. Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling.
Arribas AJ; Gómez-Abad C; Sánchez-Beato M; Martinez N; Dilisio L; Casado F; Cruz MA; Algara P; Piris MA; Mollejo M
Mod Pathol; 2013 Jul; 26(7):889-901. PubMed ID: 23429603
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
[TBL] [Abstract][Full Text] [Related]
3. Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.
Arribas AJ; Campos-Martín Y; Gómez-Abad C; Algara P; Sánchez-Beato M; Rodriguez-Pinilla MS; Montes-Moreno S; Martinez N; Alves-Ferreira J; Piris MA; Mollejo M
Blood; 2012 Jan; 119(3):e9-e21. PubMed ID: 22110251
[TBL] [Abstract][Full Text] [Related]
4. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic Gastritis.
Fernández C; Bellosillo B; Ferraro M; Seoane A; Sánchez-González B; Pairet S; Pons A; Barranco L; Vela MC; Gimeno E; Colomo L; Besses C; Navarro A; Salar A
Cancer Genomics Proteomics; 2017 Jan; 14(1):75-82. PubMed ID: 28031239
[TBL] [Abstract][Full Text] [Related]
6. The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Zamò A; van den Brand M; Climent F; de Leval L; Dirnhofer S; Leoncini L; Ng SB; Ondrejka SL; Quintanilla-Martinez L; Soma L; Wotherspoon A
Virchows Arch; 2023 Sep; 483(3):317-331. PubMed ID: 37656249
[TBL] [Abstract][Full Text] [Related]
7. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
[TBL] [Abstract][Full Text] [Related]
8. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.
Watkins AJ; Hamoudi RA; Zeng N; Yan Q; Huang Y; Liu H; Zhang J; Braggio E; Fonseca R; de Leval L; Isaacson PG; Wotherspoon A; McPhail ED; Dogan A; Du MQ
PLoS One; 2012; 7(9):e44997. PubMed ID: 23028731
[TBL] [Abstract][Full Text] [Related]
9. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
[TBL] [Abstract][Full Text] [Related]
10. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas.
Remstein ED; James CD; Kurtin PJ
Am J Pathol; 2000 Apr; 156(4):1183-8. PubMed ID: 10751343
[TBL] [Abstract][Full Text] [Related]
11. MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.
Hamadeh F; MacNamara SP; Aguilera NS; Swerdlow SH; Cook JR
Mod Pathol; 2015 Apr; 28(4):564-74. PubMed ID: 25216226
[TBL] [Abstract][Full Text] [Related]
12. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone.
de Wolf-Peeters C; Pittaluga S; Dierlamm J; Wlodarska I; Van Den Berghe H
Leuk Lymphoma; 1997 Aug; 26(5-6):467-78. PubMed ID: 9389354
[TBL] [Abstract][Full Text] [Related]
13. Identification of MNDA as a new marker for nodal marginal zone lymphoma.
Kanellis G; Roncador G; Arribas A; Mollejo M; Montes-Moreno S; Maestre L; Campos-Martin Y; Ríos Gonzalez JL; Martinez-Torrecuadrada JL; Sanchez-Verde L; Pajares R; Cigudosa JC; Martin MC; Piris MA
Leukemia; 2009 Oct; 23(10):1847-57. PubMed ID: 19474799
[TBL] [Abstract][Full Text] [Related]
14. The expression ratio of miR-17-5p and miR-155 correlates with grading in canine splenic lymphoma.
Albonico F; Mortarino M; Avallone G; Gioia G; Comazzi S; Roccabianca P
Vet Immunol Immunopathol; 2013 Sep; 155(1-2):117-23. PubMed ID: 23871213
[TBL] [Abstract][Full Text] [Related]
15. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
[TBL] [Abstract][Full Text] [Related]
16. Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas.
Bertoni F; Conconi A; Luminari S; Realini C; Roggero E; Baldini L; Carobbio S; Cavalli F; Neri A; Zucca E
Leukemia; 2000 Mar; 14(3):446-8. PubMed ID: 10720140
[TBL] [Abstract][Full Text] [Related]
17. Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma.
Munari E; Rinaldi M; Ambrosetti A; Bonifacio M; Bonalumi A; Chilosi M; Zamò A
Virchows Arch; 2012 Dec; 461(6):677-85. PubMed ID: 23064660
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profile in splenic marginal zone lymphoma.
Bouteloup M; Verney A; Rachinel N; Callet-Bauchu E; Ffrench M; Coiffier B; Magaud JP; Berger F; Salles GA; Traverse-Glehen A
Br J Haematol; 2012 Jan; 156(2):279-81. PubMed ID: 21902683
[No Abstract] [Full Text] [Related]
19. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
Dogan A; Bagdi E; Munson P; Isaacson PG
Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
[TBL] [Abstract][Full Text] [Related]
20. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
